EML2 (Gene)

Synonyms:ELP70, EMAP like 2, EMAP-2, EMAP2, EML2, ENTREZ:24139, HGNC:18035, MIM:617494, NM_001193268, NM_001193269, NM_001352051, NM_001352052, NM_001352053, NM_001352054, NM_012155, NP_001180197, NP_001180198, NP_001338980, NP_001338981, NP_001338982, NP_001338983, NP_036287, NR_147899, NR_147900, NR_147901, NR_147902, NR_147903, XM_011526694, XM_011526695, XM_011526700, XM_011526701, XM_017026550, XM_017026551, XM_024451445, XM_024451446, XP_011524996, XP_011524997, XP_011525002, XP_011525003, XP_016882039, XP_016882040, XP_024307213, XP_024307214, XR_001753642, XR_001753644, XR_001753645, XR_001753648, XR_001753650, XR_001753652, XR_935786
Omim:OMIM:617494
Id:33ebb69c-c3d5-5d7a-b114-9bcc21724315
Hgnc:HGNC:18035
Entrez:24139
Description:EMAP like 2
Enables microtubule binding activity. Involved in negative regulation of microtubule polymerization and regulation of microtubule nucleation. Colocalizes with mitotic spindle. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View EML2's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with EML2.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using EML2.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for EML2.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with EML2.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.